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ABSTRACT 
Cancer of the cervix is one of the most rapidly increasing malignancies throughout 
the world and rated as the second most common cancer in Malaysian women. A 
ligand-dependent nuclear receptor, peroxisome proliferator-activated receptor 
gamma (PPARy) has been reported to be expressed in various cancer cells 
including breast, prostate, co lorecta I and cervical cance:r. Recently, down 
regulation of PPARy has been reported in human cervical carcinoma. 
Investigations have demonstrated that activation of PPARy is linked to growth 
inhibition of various cancers by induction of necrosis, apoptosis and growth arrest. 
This study aims to identify the effect of selective PPARy ligand, 15-Deoxy-
prostaglandin J2 (15d-PGJ2) on selected apoptotic molecules in the cervical cancer 
cell line, HeLa. HeLa cells were cultured and treated with an ECso dose of 15d-
PGJ2. These cells were harvested at every sixth hour of incubation period starting 
from 0 - 72 hours. Western bJot analysis revealed that Aid expression (anti 
apoptotic) was down regulated, while caspase 9 and caspase 3· (both are pro 
apoptotic) expression was up regulated. This finding provides significant evidence 
on the mechanism of apoptotic action of PPARy ligand that is potentially useful as 
a chemotherapeutic agent. 
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ABSTRAK 
Kanser serviks merupakan penyakit yang paling menular dan kanser kedua paling 
lazim dikalangan wanita Malaysia. Reseptor gama teraktif perangsang peroksisom 
(PPARy) telah dijumpai pada pelbagai jenis sel kanser iaitu payo dara, prostat, 
kolorektal dan serviks. Kebelakangan ini, penurunan regulasi PPARy telah 
dilaporkan pada karsinoma serYiks manusia. Penyelidikan telah membuktikan , 
bahawa pengaktifan PPARy berkait rapat dengan perencatan tumbesaran pelbagai 
jenis kanser melalui nekrosis, apoptosis dan perencatan tumbesaran. Objektif 
kajian ialah untuk mengenal pasti kesan pemilihan ligan PPARy, 15-Deoksi-
prostagladin J2 (15d-PGJ2) terhadap molekul apoptosis terpilih dalam sel kanser 
serviks, sel HeLa. Sel HeLa dikultur dan dirawat dengan 15d-PGJ2 pad a dos 
ECsonya. Sel-sel ini dituai setiap enam jam bermula dari 0-72 jam semasa 
pengeramannya. Analisis Western-blot menunjukkan bahawa pengekspresan 
protein Akt (anti apoptosis) mengalami penurunan regulasi. Manakala, caspase-9 
dan 3 (kedua-duanya pro apoptosis) menunjukkan peningkatan dalam regulasi. 
Hasil penyelidikan ini memberikan bukti yang signifikan tentang mekanisma 





A balance is nonnally maintained between cell birth rate and cell death rate which 
is strictly regulated under nonnal conditions, thus avoiding any abnormal tissue or 
organ formation (Price and Wilson, 1997). A tumor or neoplasia is observed in the 
fonn of a mass of extra tissue when cells keep dividing whtle new cells are not 
needed (Tamir, 2002). 
1.1.1 Cancer of the Cervix 
Cervical cancer is one of the most common cancers in women and remains a 
significant health care problem worldwide (Jung et al" 2005). Despite significant 
advancements in the screening and treatment of cervical dysplasia, cervical cancer 
remains a threat to thousands of women annually. Cervical cancer is still a major 
cause of death in developing countries where it is generally considered to be the 
number one or two cancer-related killers of women, with nearly 500,000 new cases 
still being diagnosed worldwide every year (Monk, 2005). 
Essentially all cancers of the cervix including non-squamous tumors 
(adenocarcinomas) are related to chronic infections with the human papilloma virus 
(HPV) (Bosch et al., 1995). However, the discrepancy and high rates of HPV 
infection among women and low rates of cervical cancer development suggest that 
additional genetic events are necessary for progression to a malignant phenotype. 
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Indeed, the risk of progression is affected by many other factors including 
environmental factors and somatic genetic alterations. The identification of 
biomarkers associated with this process might help elucidate the molecular events 
and mechanisms associated with cervical carcinogenesis and to identify prognostic 
or predictive markers. 
1.1.2 Incidence of Cervical Cancer in Malaysia 
Cancer of the cervix is the second most common cancer among the women of 
Peninsular Malaysia following breast cancer. It constituted 12.9% of all female 
cancers (Figure 1.1). The National Cancer Registry (NCR), Ministry of Health, 
Malaysia reported 1,557 cases of cervical cancer in the year 2003. Cervical cancer 
incidence rate increased with age after 30 years with a peak incidence rate at ages 
60-69 years, and declined thereafter. Chinese women had the highest rate of 
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Figure 1.1 Ten most frequent cancers (females) in Peninsular Malaysia for the 
year 2003 (adapted from Lim et al., 2003). 
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1.2 Apoptosis 
Apoptosis or programmed cell death is the word derived from the ancient Greek, 
meaning "to fall away from" referring to the falling of leaves in autumn from 
deciduous trees. The term apoptosis was first introduced by Kerr and his 
colleagues in 1972 to describe the process of ultrastructural changes characteristic 
of dying cells. Apoptosis is a process of cell suicide, the mechanisms of which are 
encoded in the chromosomes of all nucleated cells. It is a crucial process for 
normal development and maintenance of tissue homeostasis by elimination of 
damaged, virally infected, or otherwise harmful cells. 
Apoptosis is also an efficient· method of preventing malignant transformation 
because it removes cells with genetic lesions. Abnormal apoptosis can thus 
promote cancer development both by allowing accumulation of dividing cells and 
by obstructing removal of genetic variants with enhanced malignant potential (Kerr 
et al., 1972). 
Apoptosis is often observed during homeostasis, embryogenesis and during the 
induction and maintenance of immune tolerance (Sambhara and Miller, 1991; 
Zychlinsky et a/., 1991). The characteristics of the apoptotic cell include chromatin 
condensation and nuclear fragmentation (pyknosis), plasma membrane blebbing 
and cell shrinkage. Eventually, the cells break into small membrane-surrounded 
fragments (apoptotic bodies), which are then cleared by phagocytosis without 
inciting an inflammatory response (Reed, 2000). 
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Apoptosis is an active and tightly regulated process that is induced by the 
activation of effector proteases called caspases that cleave specific death 
substrates, resulting in cellular disassembly. Because of the orderly way in which 
apoptosis takes place, release of inflammatory mediators in the extracellular 
environment is prevented (Hougardy et al., 2005). 
1.2.1 Mechanism of Apoptosis 
Apoptosis can take place through two central pathways, one is dependent on 
mitochondria, known as mitochondrial or intrinsic pathway and one is independent 
of the mitochondria involving the activation of caspases (cysteinyl-aspartic acid 
proteases) known as caspase or extrinsic pathway (Figure 1.2) (Sellers and Fisher, 
1999). 
The mitochondrial pathway is triggered by several stress signals, that includes 
DNA damage (induced by radiation or chemotherapeutic agents), stress molecules 
(reactive oxygen species, etc.), or growth-factor withdrawal. These. stress signals 
can trigger the release of pro apoptotic proteins from the mitochondrial 
intermembrane space into the cytosol. Bcl 2 protein family are the important 
apoptosis regulators of the intrinsic pathway, in which members are either death 
antagonists (Bcl 2, Bcl XL, etc.) or death agonists (Bax, Bak, Bad, Bid, etc.). The 
ratio of pro apoptotic to anti apoptotic Bcl 2 family proteins establishes the cellular 
sensitivity to apoptotic signals through the mitochondrial pathway. Activation of the 
mitochondrial pathway results in the release of cytochrome c and activation of 
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caspase 9, which then activates caspase 3 and therefore, leading to apoptosis 
(Hougardy et al., 2005). 
The extrinsic or caspase pathway, on the other hand, is initiated by the activation 
of death receptors (tumor-necrosis-factor-receptor superfamily; TNFR) on the cell 
membrane. Apoptosis is triggered by the binding of specific tumor-necrosis-factor-
receptor superfamily ligands, suc~ as FASL or TRAIL, to their respective receptors, 
FAS and DR4 or DR5. Death receptor activation results in the formation of an 
intracellular death-inducing signaling complex (trimerised receptor molecules, FAS-
associated death domain molecules and procaspase a molecules) which will 
activate a caspase a-initiated intracellular apoptotic cascade. This will lead to the 
cleavage of several substrates in the cytoplasm and nucleus and completion of the 
apoptotic programme (Hougardy et al., 2005). 
Activation of caspase a leads to the activation of caspase 3, either directly or 
indirectly by cleaving Bid to tBid (Figure 1.2) which will trigger. mitochondrial 
apoptotic pathway and ultimately apoptosis. 
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Figure 1.2 The central apoptotic machinery involving the caspase pathway and 
the mitochondrial pathway (modified from Seller and Fisher, 1999). 
The process of apoptosis revolves around the caspases, Bel 2 protein family and 
certain anti apoptotic proteins (Aid, etc). Caspase 8 and caspase 9 cleave and 
activate effector caspase , caspase 3. Certain anti apoptotic proteins can directly or 
indirectly inhibit caspase 9 activation through Apaf-9 or Aid, which in tum is 
antagonized by tBid. Thus showing an interconnection between the two pathways. 
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1.3 Peroxisome proliferator-activated receptors (PPARs) 
PPARs were first discovered by Issemann and Green in 1990. They are members 
of the nuclear honnone receptor superfamily, which function as ligand-dependent, 
sequence specific activators of transcription (Evans, 1988). PPARs were cloned 
and firstly characterized as orphan members of the nuclear receptor gene family 
that includes the receptors for the steroid, retinoid and thyroid hormones (Rosen 
and Spiegelman, 2001). Subsequently, various ligands (natural and 
pharmacological) for these receptors were identified (Lehmann et a/., 1995). 
Encoded by separate genes and characterized by specific tissue and 
developmental distribution patterns, PPAR are divided into three isoforms namely 
PPARu, PPAR~ or PPARo and PPARy (Mangelsdorf et al., 1995). PPARu is 
expressed in liver, intestine, pancreas, kidney, muscle, heart, skeletal muscle, 
adrenals and cells from the vascular wall. PPARy on the other hand, is mainly 
expressed in adipose tissues where it plays a role in lipid metabolism, in intestine, 
mammary gland, endothelium, liver, skeletal muscle, prostate, ,colon and in 
immune cell types throughout the body, including monocytes and macrophages. 
PPARo is expressed in a wide range of tissues, as human embryonic kidney, small 
intestine, heart, adipose tissue, skeletal muscle and developing brain, with a less-
defined function (Theocharis et a/., 2004). 
PPARy, the best characterized of the PPARs, participates in a wide range of 
biological processes such as lipid and glucose metabolism, adipocyte 
differentiation, inflammatory responses, cell proliferation, apoptosis and cancer 
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(Lehmann et a/., 1995). Therefore, PPARy has been the central issue in the field of 
molecular and clinical therapeutics, and it has now become important to determine 
the role of PPARy in major human chronic diseases such as atherogenesis and 
carcinogenesis. Pharmacological components that target PPARy can be of 
significant importance for the development of new agents for chemotherapy or 
chemoprevention of cancer (Sporn et a/., 2001). 
1.3.1 Structure of PPARy 
PPARy consists of four functional domains with five structural regions namely AlB, 
C, D, E and F domains (Figure 1.3). 
The amino terminal AlB domain is a poorly conserved domain among the three 
isoforms of PPAR. It is involved in the ligand-dependent transcriptional activation 
function-1 (AF-1) which is active in some cells. The transcriptional activity of PPAR 
can be affected by alteration in the phosphorylation of this domain by various 
signaling pathways (Boitier et al., 2003). 
The C domain is highly conserved and more frequently known as DNA-binding 
domain or DBD. The DBD contains two zinc finger patterns which bind to the 
regulator region of DNA when the receptor is activated. The 0 domain encodes for 
the flexible hinge region which allows independent movement of ligand-binding 
domain (LBO) (Boitier et a/., 2003). 
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The ElF domain or LBO contains the AF2 ligand-dependent activation domain. 
LBO has an extensive secondary structure of several alpha helices and a beta 
sheet. Natural and synthetic ligands bind to the LBO, activating the receptor. 
AlB C 0 ElF 
N C 
Activation Function I DNA-binding Hinge Ligand-binding Acti vation Function 2 
Transacti vation domain domain Transactivation 
Figure 1.3 A schematic diagram of PPAR domain structure (modified from Boitier 
et al. , 2003). 
1_3.2 Ligands for PPARy 
PPARy is activated by natural (endogenous) or synthetic (pharmalogical) ligands. 
Endogenous ligands are mostly fatty acids or their derivatives. The most potent 
endogenous PPARy activator is 15-deoxy prostaglandin J2 (15d-PGJ2), whereas 
synthetic ligands include the oral antibiotic drugs thiazolidinediones (TZDs), such 
as ciglitazone, non steroidal anti inflamatory drugs (NSAIDs) , etc. 
15d-PGJ2 is a bioactive prostanoid produced by dehydration and isomerization of 
PGD2. a cyclooxygenase product. 15d-PGJ2 is shown to be a potent inducer of 
caspase-mediated apoptosis in a variety of cells (Bailey and Hla, 1999). There are 
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reports of the inhibition of tumor-cell growth both in vitro and in vivo by 15-d-PGJ2 
in a variety of tissues, including breast, prostate, colon, lung, bladder and 
esophagus. 
1.3.3 Transcriptional activation of PPARy 
Activation of PPARy takes place by three ways (a) heat shock protein 72 pathways, 
(b) covalent modification of PPAR and (c) receptor-ligand interactions (Vamecq 
and Latruffe, 1999). PPARy forms a heterodimer with the retinoid X receptor 
(RXR). Upon ligand binding, the complex of PPAR and RXR binds to specific 
recognition sites on DNA, the peroxisome proliferator response elements (PPREs) 
and regulates transcription of specific genes which will lead to protein synthesis 
and later, biological effects (Figure 1.4). 
1.3.4 The role of PPARy in cancer 
Apoptotic cell death has been reported in a wide variety of (in vitro and in vivo) 
cancer models, following treatment with PPARy ligands (Konopleva,and Andreeff, 
2002). A variety of natural and synthetic PPARy ligands sensitize tumor but not 
normal cells to apoptosis induction by TNF-related apoptosis inducing ligand 
(TRAIL). PPARr ligands selectively reduce the levels of FLICE-inhibitory protein 
(FLIP), an apoptosis-suppressing protein that blocks early events in TRAILlTNF 
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Figure 1.4 Schematic illustration of mechanism of PPAR as ligand-activated 
transcriptional factor (modified from Theocharis et a/., 2004). 
Upon ligand binding, the PPAR forms a heterodimeric complex with RXR, that 
binds to the PPRE and drives the transcription of target genes. 
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